Saloxicin By XYMOGEN Overview & Drug Interactions

Check For Interactions With Saloxicin

Supplement: Saloxicin by XYMOGEN

Saloxicin Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Saloxicin by XYMOGEN

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

There were no interactions found with Saloxicin. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about Saloxicin interactions? Ask Dr. Brian Staiger about it by contacting him directly.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
2 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
Servings per container 60

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Salicin
120 mg
Salicin --
Boswellia serrata extract~
50 mg
Boswellia --
BerryVin(TM)
40 mg
Proprietary Blend (Herb/Botanical) --

Other Ingredients:
Rice Flour
Cellulose
Magnesium Stearate
Silicon Dioxide


Label Statments:


FDA Statement of Identity
- Dietary Supplement
Suggested/Recommended/Usage/Directions
- Directions: Take 2 capsules twice daily or as directed by your healthcare practitioner.
Precautions
- Keep out of reach of children.
- Not to be used during pregnancy and lactation unless otherwise directed by a qualified healthcare practitioner.
- Avoid if allergic/sensitive to salicylates.
- • Pharmaceutical Grade • Professional Use Only
- CAUTION: Consult with your healthcare practitioner before use.
FDA Disclaimer Statement
- *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Storage
- STORAGE: Keep tightly closed in a cool, dry place.
General Statements
- (Salix alba/Boswellia serrata)
- NEW AND IMPROVED
- This package is completely recyclable (recycle)
- EXCLUSIVE PROFESSIONAL FORMULAS
General
- TC# D3441201 REV. 071610
Brand IP Statement(s)
- XYMOGEN 2010
- NOW FEATURING 5-LOXIN(R)
- Saloxicin(TM) represents breakthrough support for alleviating discomfort related to infalmmation. White willow bark is the original source of salicin, a forerunner of aspirin. Salicin is a natural inhibitor of both the COX-2 and 5-Lipoxygenase enzymes. Saloxicin(TM) provides 120 mg salicin per serving from a 30% standardized extract of willow bark. Saloxicin(TM) also contains the most powerful of all boswellic acids, 3-0-Acetyl-11-Keto-B-Boswellic acid (AKBA). 5-LOXIN(R) is a patented boswellia extract providing 12 times more AKBA than traditional boswellia extracts.*
Formulation
- DOES NOT CONTAIN: Wheat, gluten, corn protein, yeast, soy, artificial colors, sweeteners or preservatives.
Seals/Symbols
- VEGETABLE CAPSULES

Brand Information

See all products by this brand

Researched, Developed & Distributed by:
Name XYMOGEN Exclusive Professional Formulas
Street Address 725 S. Kirkman Rd.
City Orlando
State FL
ZipCode 32811
Phone Number 800-647-6100
Web Address www.xymogen.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.